AEON Biopharma, Stock Forecast - Accumulation Distribution
| AEON Stock | 1.02 0.03 2.86% |
AEON Stock Forecast is based on your current time horizon. Although AEON Biopharma,'s naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of AEON Biopharma,'s systematic risk associated with finding meaningful patterns of AEON Biopharma, fundamentals over time.
As of the 28th of December 2025, Payables Turnover is likely to grow to 0.03, while Receivables Turnover is likely to drop 10.06. . As of the 28th of December 2025, Common Stock Shares Outstanding is likely to drop to about 547.1 K. In addition to that, Net Loss is likely to grow to about (44.9 M). | Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 7161.61 | 0.0556 |
| Check AEON Biopharma, Volatility | Backtest AEON Biopharma, | Information Ratio |
AEON Biopharma, Trading Date Momentum
| On December 28 2025 AEON Biopharma, was traded for 1.02 at the closing time. The top price for the day was 1.08 and the lowest listed price was 1.02 . There was no trading activity during the period 0.0. Lack of trading volume on December 28, 2025 did not affect price variability. The overall trading delta against the current closing price is 4.90% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare AEON Biopharma, to competition |
Other Forecasting Options for AEON Biopharma,
For every potential investor in AEON, whether a beginner or expert, AEON Biopharma,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AEON Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AEON. Basic forecasting techniques help filter out the noise by identifying AEON Biopharma,'s price trends.AEON Biopharma, Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AEON Biopharma, stock to make a market-neutral strategy. Peer analysis of AEON Biopharma, could also be used in its relative valuation, which is a method of valuing AEON Biopharma, by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
AEON Biopharma, Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of AEON Biopharma,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of AEON Biopharma,'s current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
AEON Biopharma, Market Strength Events
Market strength indicators help investors to evaluate how AEON Biopharma, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AEON Biopharma, shares will generate the highest return on investment. By undertsting and applying AEON Biopharma, stock market strength indicators, traders can identify AEON Biopharma, entry and exit signals to maximize returns.
AEON Biopharma, Risk Indicators
The analysis of AEON Biopharma,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AEON Biopharma,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aeon stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.57 | |||
| Semi Deviation | 6.26 | |||
| Standard Deviation | 7.56 | |||
| Variance | 57.1 | |||
| Downside Variance | 46.48 | |||
| Semi Variance | 39.14 | |||
| Expected Short fall | (6.81) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with AEON Biopharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AEON Biopharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AEON Biopharma, will appreciate offsetting losses from the drop in the long position's value.Moving against AEON Stock
| 0.5 | CMB | Cambium Bio | PairCorr |
| 0.37 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.32 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.31 | DSGN | Design Therapeutics | PairCorr |
| 0.31 | DWTX | Dogwood Therapeutics, | PairCorr |
The ability to find closely correlated positions to AEON Biopharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AEON Biopharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AEON Biopharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AEON Biopharma, to buy it.
The correlation of AEON Biopharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AEON Biopharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AEON Biopharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AEON Biopharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of AEON Biopharma, to cross-verify your projections. To learn how to invest in AEON Stock, please use our How to Invest in AEON Biopharma, guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AEON Biopharma,. If investors know AEON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AEON Biopharma, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AEON Biopharma, is measured differently than its book value, which is the value of AEON that is recorded on the company's balance sheet. Investors also form their own opinion of AEON Biopharma,'s value that differs from its market value or its book value, called intrinsic value, which is AEON Biopharma,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AEON Biopharma,'s market value can be influenced by many factors that don't directly affect AEON Biopharma,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AEON Biopharma,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if AEON Biopharma, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AEON Biopharma,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.